Add BrightSurf on Google Email

AI breakthrough in detecting leading cause of childhood blindness

A deep learning AI model has been developed to screen for retinopathy of prematurity (ROP) in infants at risk of blindness. The tool was trained on images of newborns and found to be as effective as senior paediatric ophthalmologists in discriminating normal retinal images from those with ROP that could lead to blindness.

SourceUniversity College London·JournalThe Lancet Digital Health·TypeComputational simulation/modeling·DateApr 27, 2023

COVID-19 can cause 'face blindness'

A Dartmouth study found that COVID-19 can cause 'prosopagnosia,' or face blindness, and impairments in navigational abilities. Researchers worked with a patient who experienced difficulty recognizing faces and navigating, leading to dissociation between face recognition and cognitive map representation.

SourceDartmouth College·JournalCortex·TypeCase study·DateMar 13, 2023

CityU neuroscientists identify a small molecule that restores visual function after optic nerve injury

A research team led by Dr. Eddie Ma Chi-him identified a therapeutic small molecule M1 that increases mitochondrial dynamics and sustains long-distance axon regeneration, restoring visual functions in mice. Regenerated axons elicited neural activities and survived for four weeks after optic nerve injury.

SourceCity University of Hong Kong·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateJan 20, 2023

Mount Sinai researchers first to identify that two separate eye diseases may contribute to common blinding eye condition

Mount Sinai researchers discovered that age-related macular degeneration (AMD) may be caused by two distinct types of deposits in the retina: drusen and subretinal drusenoid deposits (SDDs). Early intervention with vitamin supplements can slow down drusen formation, while SDDs pose a greater threat to advanced AMD.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalEye·TypeObservational study·DateJan 9, 2023

NIH researchers develop gene therapy for rare ciliopathy

Researchers have developed a gene therapy that rescues cilia defects in retinal cells affected by Leber congenital amaurosis, a disease causing blindness in early childhood. The therapy restores opsin protein concentration in photoreceptor outer segments, suggesting functional NPHP5 may stabilize the primary cilium gate.

SourceNIH/National Eye Institute·JournalStem Cell Reports·TypeExperimental study·DateSep 8, 2022

Study uncovers how blind and visually impaired individuals navigate social challenges

A recent study highlights uncomfortable social situations people with blindness face, as well as strategies they use to navigate them. Researchers found techniques for avoiding awkward encounters, recovering from them, and even constructive ways allies can support individuals with visual impairment.

SourceNorth Carolina State University·JournalJournal of Social and Personal Relationships·TypeObservational study·DateAug 9, 2022

New study indicates sight problems may increase dementia risk in older adults

A systematic review and meta-analysis of 16 studies involving 76,373 participants found a significant association between visual impairment and cognitive decline in older adults. The study highlights the need for further research on the effectiveness of treating sight problems to prevent cognitive impairment and dementia.

SourceTaylor & Francis Group·JournalAging & Mental Health·TypeSystematic review·DateJun 24, 2022

U.S. insurance claims show strong link between ED medications and vision problems

A large US study confirms a strong link between ED medications and vision problems, including an 85% increased risk of developing serious eye conditions. Regular use of Viagra, Cialis, Levitra, or Stendra may lead to side effects such as age-related macular degeneration (AMD) and retinal vein occlusion (RVO).

SourceUniversity of British Columbia·JournalJAMA Ophthalmology·TypeData/statistical analysis·DateApr 7, 2022

Improved retinal transplant technique ready for clinical trials

Researchers at RIKEN have developed a new retinal transplant technique by engineering human-derived retina sheets to lose bipolar cells, allowing better connections to host retinas and improved responses to light. The technique has shown substantial functional improvement in animal studies and is now poised for human clinical trials.

SourceRIKEN·JournaliScience·DateJan 25, 2022

Largest population-based study of "lazy eye" reveals public health’s blind spots

A recent study of 1.5 million Israeli teens found that approximately 1% have lazy eye, with a decline in incidence over the past two decades. Socioeconomic factors and ultra-orthodox upbringing are linked to increased risk, while immigrants from certain countries have a higher prevalence

SourceThe Hebrew University of Jerusalem·JournalEuropean Journal of Public Health·TypeData/statistical analysis·DateSep 13, 2021

Gender influences symptoms of genetic disorder

A new study reveals that girls with NF1 are at greater risk of vision loss from brain tumors, while boys are more vulnerable to learning disabilities. The research identifies gender-linked differences in male mice that may help explain these findings.

SourceWashU Medicine·JournalAnnals of Neurology·DateFeb 6, 2014